J7631 – Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7631
- Long description
- Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- Short description
- Cromolyn sodium noncomp unit
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
D1GDrugs Administered through DME- Added
- January 1, 2000
- Last change
- January 1, 2008 – No change
Frequently asked questions
What is HCPCS code J7631?
J7631 is a HCPCS Level II code for cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams.
Does Medicare cover J7631?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7615 – Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
- J7620 – Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
- J7622 – Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7624 – Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7626 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
- J7627 – Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
- J7628 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7629 – Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7632 – Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7633 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
- J7634 – Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
- J7635 – Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7636 – Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7637 – Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7638 – Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7639 – Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.